Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02BFK
|
|||
| Former ID |
DNC006129
|
|||
| Drug Name |
4-(3-chlorophenylethynyl)-2-methylthiazole
|
|||
| Synonyms |
CHEMBL202124; 4-(3-chlorophenylethynyl)-2-methylthiazole; SCHEMBL4153004
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H8ClNS
|
|||
| Canonical SMILES |
CC1=NC(=CS1)C#CC2=CC(=CC=C2)Cl
|
|||
| InChI |
1S/C12H8ClNS/c1-9-14-12(8-15-9)6-5-10-3-2-4-11(13)7-10/h2-4,7-8H,1H3
|
|||
| InChIKey |
ORFSHDWOPQJKQL-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic g... J Med Chem. 2006 Feb 9;49(3):1080-100. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.